The Trump administration wants to explore how to safely import pharmaceuticals from other countries in order to counteract major hikes in the price of drugs. Such a policy would represent a major shift from current procedure.

Health and Human Services Secretary Alex Azar requested on Thursday that the Food and Drug Administration establish a working group to examine safe importation. The request is part of a larger effort by the Trump administration to tackle high drug prices, a growing driver of healthcare costs in the U.S.